Table 1.
The distributions of demographical characteristics in 579 patients with prostate cancer.
| Variable | Patients (N=579) |
|---|---|
| Age at diagnosis (years) | |
| ≤ 65 | 245 (42.3 %) |
| > 65 | 334 (57.7 %) |
| PSA at diagnosis (ng/mL) | |
| ≤ 10 | 309 (53.4 %) |
| > 10 | 270 (46.6 %) |
| Pathologic Gleason grade group | |
| 1+2+3 | 484 (83.6 %) |
| 4+5 | 95 (16.4 %) |
| Clinical T stage | |
| 1+2 | 501 (86.5 %) |
| 3+4 | 78 (13.5 %) |
| Pathologic T stage | |
| 2 | 306 (52.8 %) |
| 3+4 | 273 (47.2 %) |
| Pathologic N stage | |
| N0 | 530 (91.5 %) |
| N1 | 49 (8.5 %) |
| Seminal vesicle invasion | |
| No | 452 (78.1 %) |
| Yes | 127 (21.9 %) |
| Perineural invasion | |
| No | 155 (26.8 %) |
| Yes | 424 (73.2 %) |
| Lymphovascular invasion | |
| No | 482 (83.2 %) |
| Yes | 97 (16.8 %) |
| D'Amico classification | |
| Low risk | 60 (10.4 %) |
| Intermediate risk | 220 (38.0 %) |
| High risk | 299 (51.6 %) |